Professor of Medical Oncology at the University of Oxford and Director of the Cancer Research UK Medical Oncology Unit and a NIHR Comprehensive Biomedical Research Center.
Adrian Harris, MD, DPhil is Professor of Medical Oncology at the University of Oxford and Director of the Cancer Research UK Medical Oncology Unit. He is a Consultant Medical Oncologist at the National Health Service, Oxford Radcliffe Hospital Trust, an NIHR Comprehensive Biomedical Research Centre designated by Cancer Research as one of three Comprehensive Cancer Centres.
Professor Harris's research is on tumour angiogenesis, hypoxia and the metabolic response to hypoxia as key targets for anti-cancer therapy. He is interested in understanding the basic biology and science of disease, how this could be applied in the development of new treatments and selecting the right patients for the right therapies.
He received his Honours bachelor's degree in Medicine and Surgery in 1973 at Liverpool University but undertook an intercalated Biochemistry degree (first class honours) in 1969. He worked at Oxford University from 1975-1978, where he conducted research on mechanisms of resistance to anti-cancer drugs. He then took up a lectureship at the Royal Marsden Hospital where he developed an interest in the endocrine therapy of breast cancer with Professor Ian Smith and helped develop early aromatase inhibitors.
In 1981 he was appointed Professor of Clinical Oncology at the University of Newcastle Upon Tyne and in 1988 he was invited to Oxford to take up the foundation chair in Medical Oncology and lead the CRUK Molecular Oncology Laboratories at the Weatherall Institute of Molecular Medicine, one of the leading basic science institutes in the United Kingdom.